Filing Details
- Accession Number:
- 0001628280-20-017712
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-22 18:39:27
- Reporting Period:
- 2020-12-21
- Accepted Time:
- 2020-12-22 18:39:27
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1645113 | Novocure Ltd | NVCR | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1632237 | Ely Benaim | C/O Novocure Inc., 20 Valley Stream Parkway, Suite 300 Malvern PA 19355 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2020-12-21 | 1,833 | $47.56 | 31,189 | No | 4 | M | Direct | |
Ordinary Shares | Disposition | 2020-12-21 | 1,833 | $156.71 | 29,356 | No | 4 | S | Direct | |
Ordinary Shares | Acquisiton | 2020-12-21 | 651 | $83.30 | 30,007 | No | 4 | M | Direct | |
Ordinary Shares | Disposition | 2020-12-21 | 651 | $156.71 | 29,356 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Ordinary Shares | Options to Buy Ordinary Shares | Disposition | 2020-12-21 | 1,833 | $0.00 | 1,833 | $47.56 |
Ordinary Shares | Options to Buy Ordinary Shares | Disposition | 2020-12-21 | 651 | $0.00 | 651 | $83.30 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
12,831 | 2029-05-07 | No | 4 | M | Direct | |
4,555 | 2029-07-30 | No | 4 | M | Direct |
Footnotes
- Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Benaim.
- Fully vested as of the date hereof.